Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CMA1 | P23946 | 1/20 | 0.76 |
| ▸ | TSHR | P16473 | 4/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.66 |
| ▸ | PKM | P14618 | 1/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | HPGD | P15428 | 3/20 | 0.54 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.53 |
| ▸ | HSP90B1 | P14625 | 1/20 | 0.53 |
| ▸ | TRAP1 | Q12931 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1080694 | 0.83 | CMA1 (0.76) | CMA1TSHRKMT2ASMN1; SMN2PKM | |
| SCHEMBL4014992 | 0.80 | CMA1 (0.66) | CMA1TSHRKMT2ASMN1; SMN2PKM | |
| SCHEMBL3804014 | 0.80 | CMA1 (0.50) | CMA1TSHRKMT2ASMN1; SMN2PKM | |
| SCHEMBL19500873 | 0.80 | KMT2A (1.00) | CMA1TSHRKMT2ASMN1; SMN2PKM | |
| SCHEMBL13657468 | 0.79 | CMA1 (0.64) | CMA1TSHRKMT2ASMN1; SMN2PKM | |
| SCHEMBL4013109 | 0.78 | CMA1 (0.62) | CMA1TSHRKMT2ASMN1; SMN2PKM | |
| SCHEMBL4017118 | 0.78 | CMA1 (0.62) | CMA1TSHRKMT2ASMN1; SMN2PKM | |
| SCHEMBL6333504 | 0.78 | CMA1 (0.62) | CMA1KMT2ASMN1; SMN2PKMALDH1A1 | |
| SCHEMBL14681264 | 0.76 | TSHR (0.64) | CMA1TSHRKMT2ASMN1; SMN2PKM | |
| SCHEMBL13657384 | 0.76 | CMA1 (0.64) | CMA1TSHRKMT2ASMN1; SMN2PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060211724-A1 | Hiv integrase inhibitors | VERSCHUEREN GASTON W | 2006-09-21 | — | — | US | disclosed |
| CN-1812992-A | HIV integrase inhibitors | TIBOTEC PHARM LTD (IE) | 2006-08-02 | — | — | CN | disclosed |
| EP-1625130-A2 | HIV INTEGRASE INHIBITORS | Tibotec Pharmaceuticals Ltd. (IE) | 2006-02-15 | — | — | EP | disclosed |
| WO-2004096807-A2 | HIV INTEGRASE INHIBITORS | TIBOTEC PHARMACEUTICALS LTD. (IE) | 2004-11-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060211724-A1 | Hiv integrase inhibitors | SULT1A1, SULT2A1, SULT1E1 | CMA1 2557/4885TSHR 3033/4885KMT2A 1121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.